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Preterm birth poses a global challenge with a continuously increasing disease burden during the last decades. Advances in
understanding the etiopathogenesis did not lead to a reduction of prematurely born infants so far. A balanced development of
the host microbiome in early life is key for the maturation of the immune system and many other physiological functions. With
the tremendous progress in new diagnostic possibilities, the contribution of microbiota changes to preterm birth and the acute
and long-term sequelae of prematurity have come into the research focus. This review summarizes the latest advances in the
understanding of microbiomes in the amniotic cavity and the female lower genital tract and how changes in microbiota structures
contribute to preterm delivery.The exhibition of these highly vulnerable infants to the hostile environment in the neonatal intensive
care unit necessarily entails the rapid colonization with a nonbalanced microbiome in a situation where the organism is still very
prone and at an early stage of development. The global research efforts to decipher pathologic changes will pave the way to new
pre- and postnatal therapeutic concepts.
1. Introduction
Microbiomes comprise commensal, symbiotic, and
pathogenic bacteria, fungi, and viruses, which form an
ecological entity and interact with themselves and with their
particular host. For a long time, it has been assumed that
microbiota colonization is restricted to body surfaces like
skin and the gastrointestinal tract. However, it became clear
in the recent years thatmicroorganisms reside in nearly every
human tissue including themammary glands, the ovaries, the
uterus, and the placenta. Thus the human body is colonized
by trillions of microbial inhabitants. They constitute a
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diverse and individually varying ecological community
which in addition changes with age [1]. In line with this, the
former theory that the amniotic cavity constitutes a sterile
environment had to be abandoned. It became clear that the
healthy maternofetal unit is colonized with microbes and
that this is a prerequisite for immune maturation as well as
metabolic and hormonal homeostasis. Fetal life and the first
year of life are a life span which is critical for the development
of a well-functioning immune system and maintenance of
long-term health. For these reasons, negative early-life events
pose a special risk to somatic and psychomotor development.
Pathologic changes in microbiomes predispose or contribute
to acute and chronic morbidities of every organ at any age.
Furthermore, functional changes in microbiomes trigger
infectious complications. In this review we present the latest
insights into the structure and function of our microbiome
and how pathologic changes contribute to preterm labor,
premature birth, and the acute and long-term sequelae of
prematurely born infants. Despite the fact that fungi and
viruses are part of microbiomes, most research efforts so far
clearly focused on bacterial diversity. Thus, other microbes
than bacteria are mostly excluded in this review, simply
because no data is available.
2. Functional Traits of the Microbiome
of the Lower Urogenital Tract and the
Fetomaternal Unit
The amniotic cavity has long been viewed as a sterile
environment where the fetus is protected from the harmful
external influences and threats. First reports emerged with
the beginning of the new millennium, which questioned
this hypothesis and described an intrauterine and placental
microbial environment [2–4]. With the advancements in
molecular techniques it became clear that the placenta, the
amnion, and the fetus share large proportions of a common
microbiome and that the maternal microbiome drives the
development of the fetal immune system [5, 6]. The pla-
cental microbiome, under physiologic conditions, harbors
nonpathogenic commensals including Firmicutes, Teneri-
cutes, Proteobacteria, Prevotella, Neisseria, Bacteroidetes,
and Fusobacteria but also potential pathogenic species like
Escherichia coli [7]. As its detection is based on molecular
techniques, the scientific discussion is ongoing whether the
placental microbiome contains viable microbiota or just
microbial components. Nonetheless, a regulatory function is
currently assumed [8].
The vaginal microbiome resembles that of the cervix
and is physiologically dominated by Lactobacillales, but
Clostridiales, Bacteroidales, and Actinomycetales are also
regularly detected. Bacterial community differences and
shifts are almost exclusively detected between different Lac-
tobacillus strains without any negative impact on pregnancy
outcomes. During pregnancy, microbial richness and diver-
sity are reduced along with an increased bacterial load. At
the same time, the prevalence of potential pathogens like
microbial species of ureaplasma and mycoplasma is reduced.
The taxonomic composition of the microbial community
of the vagina remains stable during pregnancy with an
increase of the microbial diversity before birth of the healthy
infant at term. These data lead to the conclusion that the
composition of the vaginal microbiota is tightly regulated
during pregnancy and that the switch to the nonpregnant
situation precedes and maybe even triggers birth [9–13].
Microbial diversity and orchestrated structural changes
during early life are key features for a healthy microbiome.
Ethnicity and regional differences have a key impact on the
vaginal microbiota. It remains to be determined whether
changes in the vaginal microbiome observed in Hispanic
and black women account for the increased rate of preterm
delivery in these ethnic groups [14–16].
The fetus swallows huge amounts of amniotic fluid. This
explains why its gut gets colonized with the intrauterine
microflora already before birth. After birth, the infant gets
rapidly colonized by maternal vaginal, gut, and skin micro-
biota. In the term infant, the mode of delivery either by
vaginal birth or by caesarian section determines microbial
diversity and whether the gut is primarily colonized by the
maternal vaginal and fecal or the skin microbiota. These
data are a first scientific indication that early events have a
long-term health impact on microbiota structures [17–20].
In contrast to the situation at term, the decision of preterm
delivery by caesarian section or vaginal birth does not
have an impact on gut microbial diversity and longitudinal
microbiota changes and microbiota display a pattern distinct
from that at term. As an example of the disparities, preterm
microbiota lack Bacteroides species, which display a delayed
colonization pattern after caesarian section. Althoughmicro-
biomes are principally able to adapt to that of the term
infant within several weeks, the intrauterine and postnatal
miscolonization poses a major threat to the health of the
preterm infant [21–23]. The following chapters summarize
the substantial advances in our understanding of microbiota
structures and dynamics during pregnancy and after birth.
3. Pathologic Changes of the Microbiome
Associated with Premature Labor and
Preterm Delivery
The reasons for preterm labor comprise a multitude of
different causes including maternal psychosocial distress,
hormonal changes, uterine overdistension, cervical disease,
vascular and maternal disorders, and breakdown of the
maternal-fetal tolerance [24]. Among these, infection and
inflammation are the main drivers of preterm labor and
account for at least one half of preterm births [24–26].
Till today, histopathology is the gold standard to deter-
mine chorioamnionitis in contrast to the low sensitivity
and specificity of clinical evaluation scores and laboratory
parameters [27]. In severe chorioamnionitis, a typical pat-
tern with an increase in bacterial abundance and reduced
diversity with the dominance of bacteria has been observed,
which is not seen in the physiologic situation [28]. The
evolutionary attenuation of the maternal and fetal immune
system enables the intrauterine growth of the fetus, but
immune tolerance of the mother at the same time puts the
fetus at risk for infection [29]. The diagnosis of a maternal
infection is of crucial importance, as the fetus, exposed to
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microbiota in the amniotic cavity, experiences an immuno-
logic adaptation. This new phenomenon is termed the so-
called immunotolerance or immunoparalysis. This means
that the previous or ongoing exposure to microbiota sup-
presses the necessary physiologic immune response and that
an adequate increase in classicalmarkers of inflammation and
infection is not guaranteed [30, 31]. The placental microbiota
structures display distinct patterns in term and preterm born
infants, independent of the mode of delivery, and can be
influenced by living conditions like excessive weight gain
during pregnancy [32, 33]. Microbial species of ureaplasma
and mycoplasma but also Aerococcaceae, Bifidobacteriaceae,
and Fusobacteria predominate or are even exclusively present
in the membranes of preterm delivered babies. Conversely,
bacterial dysbiosis and inflammation in the fetal membranes
can occur without preterm labor and without the typical
clinical signs and seems not to put the fetus at risk for
preterm delivery [2, 4, 34]. In the situation of preterm labor,
a shift of microbiota with reduced microbial diversity takes
place. Latest molecular techniques proved superior to detect
microbial invasion and diversity compared to conventional
culture techniques, which opened a new diagnostic window
of opportunity [35]. The long-prevailing concept of bacterial
ascension or transmission from the urogenital tract as the
main driver of chorioamnionitis and amniotic inflammation
was based on the bacteriological detection of microbes
typically present. They include bacterial species of the genera
Streptococcus, E. coli, Gardnerella spp., Prevotella, Gonorrhea,
Treponema, Chlamydia, Ureaplasma, andMycoplasma as well
as yeasts like Candida [13, 36–38]. Further species including
anaerobic Fusobacteriaceae were recently detected by the
non-cultivation-based techniques.
In fact, the microbiome gets dominated by abundance
of bacteria from the urogenital tract, the gut, and the oral
cavity (Figure 1). This shift is accompanied by alterations in
microbial and metabolic pathways, which are suggested to
contribute to preterm labor and birth [34, 39]. The lower
urogenital tract and the perianal region constitute amicrobial
epitope which is highly influenced by the bacterial coloniza-
tion of the gut and the local viability conditions.Microbiomes
change during pregnancy, and differences in composition
have long been acknowledged to account for variations
in preterm birth rates [11, 16, 40, 41]. The reduction of
microbial richness and diversity and changes in microbiome
structure seem to occur early, in the first to second trimester
of pregnancy, and there seem to exist racial disparities
[14, 42–44]. That is, the cervical microbiota from women
with Chlamydia trachomatis infection, which predisposes for
preterm birth, differ completely from that of healthy women
with respect to microbial diversity. They display a change in
microbial taxa away from Lactobacillus species to anaerobes
[43, 45]. While Lactobacillus species that dominated cervical
microbiota have a lower risk of invasion of the amniotic cavity
and chorioamnionitis after premature rupture ofmembranes,
the prevalence of Gardnerella and Sneathia increases the
probability [46].
Microbiota from the oral cavity can equally induce
chorioamnionitis, when they are translocated via the blood-
stream or by sexual practices. Members of the genera
Streptococcus, Porphyromonas, Filifactor, Campylobacter, and
Fusobacterium represent species which were repetitively
connected with preterm labor. The scientific data point
out that gut microbiota constitute the third source for
bacterial translocation and can cause amniotic infection
and chorioamnionitis. Reduction in microbial diversity and
changes in gut microbiota occur during pregnancy with a
dominance of Proteobacteria and Acinetobacteria away from
Bifidobacterium, Streptococcus, Clostridiales, andBacteroides,
which predisposes for preterm delivery and disease [47–
51]. The pathologic changes in the amniotic microbiome
are retrieved in meconium samples from preterm infants
with a high accordance. Microbiota are shifted to strains
of the genera Enterobacter, Enterococcus, Photorhabdus, and
Tannerella, which are known for their inflammatory, and
potentially preterm birth inducing, properties [39, 52, 53].
In line with these observations, the type of nutritional diet
or an active inflammatory bowel disease impacts on the gut
microbiota composition, and the risk of preterm delivery is
increased in these patients. This underlines the concept that
a change in maternal gut microbiota is one of the responsible
triggers [54].
4. The Consequences for the Premature Infant
Inflammatory diseases represent the biggest threat to the
preterm infant and affect all organs, including the immature
lung, cardiovascular system, immune system, brain, eye, and
gastrointestinal tract, with acute and persistent consequences
for the patient’s health. Infection accounts for or aggravates
acute respiratory distress, leakage, and arterial hypotension
after birth. Simultaneously, all organs are at high risk for sec-
ondary complications including NEC, nosocomial infection,
cerebral damage, retinopathy of prematurity, and endocrino-
logical nonbalance. Infection promotes the establishment of
BPD and somatic and developmental disorders [55].
Antibiotic therapy is aimed at combating life-threatening
pre- or postnatal infections with pathogenic microbiota, but
they cannot reduce or prevent the concomitant inflammatory
organ damage. So far, most pathomechanistic insights are
available for the inflammatory damage to the immature
lung and efficient therapeutic interventions are restricted
to a very limited number of drugs. The reason for the
so far unsuccessful establishment of effective therapeutic
interventions is based on the complexity of the involved
pathomechanisms. The complex interplay between different
central pathways and persistent cell phenotype distortion
after a one-time injury poses further obstacles that need
to be bypassed to reach therapeutic efficiency [56–59]. The
following sections are dedicated to the detailed description
of some of the most important disease burdens provoked
by microbial dysbiosis. They summarize the actual status of
therapeutic interventions with proven efficacy. Special focus
is drawn to highlight the impact of the disturbed endogenous
gut microbiome (Figure 2).
5. Microbiota of the Airways and
Bronchopulmonary Dysplasia
Bronchopulmonary dysplasia (BPD) is the chronic lung
disease of the preterm infant leading to life-long limitations
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Figure 1: Origin of microbiota in the amniotic cavity leading to preterm birth: The microbiome in the amniotic cavity has long been
thought to originate exclusively from the vaginal and cervical microbiome. But microbiota from the oral cavity, gut, and even the placenta
provide a substantial contribution to the microbiome in the amniotic cavity mainly via haematogenic spread.
in lung function [59]. On a pathophysiologic level, BPD
is characterized by distorted alveolar and vascular growth
in the saccular stage of lung development. Central to the
pathogenesis is the pulmonary inflammatory response after
birth, which is mainly provoked by pre- and postnatal infec-
tions and the life-saving therapies of mechanical ventilation
and oxygen supply [58]. While chorioamnionitis and special
pathogens like bacterial species derived from ureaplasma are
well acknowledged to contribute to the disease in animal
trials and preterm cohort studies, the impact of microbial
colonization of the respiratory tract in utero and after birth
was neglected until recently [60–63]. This is surprising,
considering the tremendous impact of the microbiome on
other pulmonary diseases and immunity of the lung includ-
ing asthma, pneumonia, cystic fibrosis, COPD, and even
pulmonary fibrosis. The airway of the preterm infant is not
sterile at birth and its microbiome is highly influenced by the
microbiome of the amniotic fluid. Differences in colonization
and clinical parameters allow the categorization into disease
clusters, which are predictive for the clinical course and
outcome [64]. Reduced microbial diversity at birth, initial
abundance of ureaplasma species in tracheal aspirates of
ventilated preterm infants, and more pronounced changes
in the longitudinal microbial community are associated with
higher severity of BPD. The association of a predominance
of Proteobacteria and decrease in Lactobacillus species in
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Figure 2: Impact of gut microbiota on the acute and long-term morbidities in the preterm infant: The gut microbiota exerts a central
influence on human health. In the preterm infant, their impact on NEC and nosocomial infection is well recognized. First studies hint to an
important impact on somatic growth, psychomotor development, autonomic regulation, and hormonal balance. In contrast, the contribution
to the other acute and long-term sequelae remains to be determined.
the airways of infants with severe BPD was recapitulated
in the murine animal model with major impact on the
regulation of central lung signaling pathways [65–68]. The
well-accepted further dimension arising from the interaction
of gut microbiota with the lung in other pulmonary diseases
termed the gut-lung axis needs to be established for BPD.
6. The Significant Impact of Microbiota on
Necrotizing Enterocolitis
In contrast to BPD, the important contribution of bacteria
to the pathogenesis of necrotizing enterocolitis, which
constitutes one of the most devastating morbidities of
prematurity, is well established. NEC is considered to
be a multifactorial disease. The inflammatory response
of the gut to microorganisms is a central hypothesis of
necrotizing enterocolitis pathogenesis [69, 70]. The great
beneficial advantages of breast milk provision are attributed
to microbiota diversity and the shaping of immunologic
properties [71]. In contrast, antibiotic therapy drives
microbial dysbiosis and increases the risk of necrotizing
enterocolitis [72]. Derived from these findings, the benefits of
prophylactic application of probiotic strains of Bifidobacteria,
Lactobacillus, and Saccharomyces was tested in varying
experimental and clinical settings. Despite the heterogeneity
of results and the need for large-scalemeta-analyses, themost
recent reviews clearly established a benefit of probiotics to
nearly halve the risk of necrotizing enterocolitis and to reduce
the incidence of nosocomial infection and death [73, 74].
Postnatally, the gut gets colonized by Gram-positive and
Gram-negative bacteria mostly with a facultative or strictly
anaerobic metabolism. In the term infant the gut is dom-
inated by Bifidobacteriales and Bacteroides. In the preterm
infant the presence of a large number of different genera
including Anaerococcus, Aquabacterium, Bacillus, Bifidobac-
terium, Corynebacterium, Micrococcus, Oceanobacillus, Pro-
pionibacterium, Pseudomonas, Rothia, Sarcina, Sneathia, and
Streptococcus has been described. As a general phenomenon,
the gut microbiome of the preterm infant is dominated by
Proteobacteria even when breast milk provision is assured
and the appearance of Clostridium and Vellonella species is
retarded [53, 75–78]. The microbiome is highly impacted by
pre- and postnatal antibiotic therapy [79]. In this context,
probiotic therapy aims to establish and maintain physiologic
gut microbiota structures.
A strong dominance of Gram-negative bacteria and a
decrease in anaerobic bacteria are described before onset of
clinical symptoms of necrotizing enterocolitis, but whether
altered microbial structures predispose for necrotizing
enterocolitis or are a consequence of gastrointestinal or
immunologic immaturity remains an open question. The
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Figure 3: Factors determining the composition of gutmicrobiota in the preterm infant:Themicrobiome of the gastrointestinal tract of the
preterm infant varies widely from that at term and is impacted by a plenty of endogenous and environmental factors and pre- and postnatal
therapeutic interventions.
discrepancies in microbiome structures between the feces
and samples obtained from the oral cavity or stomach and the
impact of microbial dysbiosis of the upper gastrointestinal
tract are awaiting further clarification. Presence of Gram-
negative bacteria and staphylococci allows the conclusion
of their acquisition from the NICU environment [80].
Microbial colonization can be separated into peripartal
acquisition as described, i.e., for Escherichia coli and Candida
albicans and hospital acquiredmicrobial structures including
Klebsiella, Enterobacter, and Acinetobacter species and
Candida species other than Candida albicans [81]. Taken
together, studies of the intestinal microbiome revealed a
reduction of bacterial diversity and a shift of microbiota
from Bacteroidetes and Firmicutes towards Proteobacteria
and potentially pathogenic species including Staphylococcus
aureus, Escherichia coli, Shigella spp., Citrobacter spp., and
Klebsiella spp. before the onset of clinical symptoms of
necrotizing enterocolitis [78, 82–85].
7. Microbial Dysbiosis and the Risk for
Nosocomial Infection
Nosocomial infections pose a special risk to the premature
infant. Due to the immaturity and immunologic incom-
petence of the immune system, the preterm infant is par-
ticularly vulnerable to nosocomial infections in the hostile
environment of the neonatal intensive care unit [30, 31,
86–90]. Furthermore, therapies with antenatal steroids and
magnesium as well as small-for-gestational-age status and
antenatal smoke exposure seem to further impact and dimin-
ish the immunologic response capacity [91–94]. Therefore,
skin and gut microbiota colonization and maturation are
important prerequisites to prevent pathogen overgrowth and
nosocomial infection. The skin of the healthy term and
preterm infant is dominated by Firmicutes, Actinobacteria,
Proteobacteria, and Bacteroidetes exposing them to nosoco-
mial infection [95, 96]. The physiologic dominance of gut
microbiota structures by Bifidobacteriamay serve as a protec-
tive factor from gut-epithelial translocation. The differences
in gut microbiota between preterm and term born infants at
the onset of sepsis are used as an explanation for the vulner-
ability of the preterm infant and the important role of the gut
microbiome in disease initiation. Concordance of microbiota
isolated from the gut of infants with sepsis and bacteria
identified in positive blood cultures supports this assumption
[97–99]. The actual pathomechanistic understanding sug-
gests the following sequence: The preterm infant is exposed
to the hostile environment of the neonatal intensive care
unit and gut microbiota display a big disparity after birth. A
uniform microbiome is established within the first weeks of
life with prevalence of highly pathogenic bacteria including
Staphylococcus, Enterococcus, and several Enterobacteriaceae,
while Bifidobacteria are infrequently detected. Reduction in
microbial diversity with predominance of Staphylococci is
again another feature predisposing for late-onset infection
[100]. Not surprisingly, pre- or postnatal antibiotic therapy
reduces microbial diversity and impedes the establishment
of physiologic gut microbiota with a shift from Firmicutes
and Bacteroidetes towards Proteobacteria andActinobacteria
[85, 101–103].
Taken together, the gut microbiome of the preterm infant
is highly impacted by endogenous and environmental factors
and maternal and postnatal therapeutic interventions which
accounts for the high susceptibility for nosocomial infection
(Figure 3).
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8. The Gut-Brain Axis in Prematurity
Brain development and function undergo fundamental steps
in the last trimester and in the first year of life.Thephysiologic
steps of brain folding and the developmental steps of the
brain connectome far outreach the increase in brain volume
and highly impact functionality.Their functional importance
can be derived from preterm infants with severe limitations
in brain functions, which display tremendous alterations in
these critical steps [104, 105]. More and more data from
animal and human studies support the finding that the
gut microbiome, especially at early postnatal stages, has
tremendous impact on behavioral and stress responses later
in life [106–110]. The term gut-brain axis summarizes not
only themultiple and complex functions of the cerebrum, but
endocrine homeostasis, the sympathetic-parasympathetic,
and even the enteric nervous system. The neurologic dis-
orders comprise diseases like autism spectrum disorders,
depression, and anxiety which are frequently observed in
former preterm infants and restrict their quality of life
beyond intelligence and gross and fine motor functions
[111, 112]. Even persisting hormonal dysregulations in former
preterms are coming into the focus of research [113]. Under-
lining the functional relevance of the gut-brain axis to the
neurodevelopmental outcome after prematurity, higher and
persisting prevalence of Bifidobacteria in the gut microbiome
is associated with improved scores for mental development
at 24 months [114]. Convincing animal data demonstrate the
far-reaching impact of pre- and postnatal microbiota changes
on brain development and the different functional regions
which were reproduced in first association studies in children
[115–117]. The gut-brain axis is not a one-way but the gut and
the brain impact each other bidirectionally which can lead to
multiplication in effect size [118–120]. This comes especially
true as the preterm infant is exposed to high stress levels and
repeated painful procedures [121]. Future studies will have to
elucidate how microbiota modulate brain development and
function physiologically compared to preterms, how these
early life events lead to persisting psychomotor sequelae, and
whether microglia cells are the only targets within the central
nervous system [122]. Vice versa, it remains to be determined
how impaired brain function impacts physiologic microbiota
structures.
9. Breast Milk and Beyond to Shape
Physiologic Microbiota Structures
Breast milk is the optimal nutrition of the preterm infant
with respect to acute and long-term health, somatic growth,
and psychomotor development. It is well established from
studies in healthy newborn that the infant’s microbiome
is crucially promoted and shaped by the microbiota, anti-
inflammatory and antioxidative properties, growth factors,
hormonally active substances, and cytokines provided by
breast milk feeding. Overall, physiologic gut microbiota
establishment and enrichment are facilitated by breast milk
[69]. The maternal microbes excreted from the mammary
gland, the contact to the skin of the breast, and the nutritional
components of breast milk enable the maturation of immune
functions and the establishment of a stable physiologic rich
and diverse microbiome with a dominance of Bifidobacteria
and Lactobacillus species but also presence of species of
the genera Staphylococcus, Streptococcus, Propionibacterium,
Bacteroides, Rothia, Enterococcusi, and Pseudomonas [99,
123–129]. But also strictly anaerobic gut commensals from
the Clostridiaceae including Blautia, Clostridium, Collinsella
and Veillonella species were detected in breast milk together
with Coprococcus, Faecalibacterium, and Roseburia species,
which were simultaneously isolated from the mothers’ breast
milk and stool. This allows the conclusion that additionally
to the skin-gut axis a maternal gut-breast microbiome axis
exists and that the infants’ gut microbiome is shaped by
the maternal gut microbiome [128, 130, 131]. Gut microbiota
composition after preterm birth differs from that of mothers
who delivered at term with a shift from Bifidobacterium to
Enterococcus species. It is impacted by perinatal maternal
antibiotic therapy with a decrease in Lactobacillus, Bifidobac-
terium, Staphylococcus, and Eubacterium species [132]. For-
mula fed infants display a further reducedmicrobial diversity
and the dominance of Enterobacteriaceae, Coriobacteriaceae,
and Bacteroides [95, 126]. In preterm infants at high risk of
gut microbial dysbiosis, probiotic therapy with the bacterial
commensals identified in the previously mentioned studies
proved overall efficient to reduce the incidence of necrotizing
enterocolitis, sepsis, and death. However, the optimal strain
or formula and the duration of application await further
exploration [73, 74]. Lactoferrin, a protein of the transferrin
family with broad antimicrobial action, stands for the steep
rising gain of knowledge about the gut microbiota shaping
functions of breast milk. Its recombinant application does
not only reduce the risk for device associated infections
but modulates the fecal microbiome towards the physiologic
situation [133]. In contrast to these medical therapeutic
interventions, skin-to-skin care is an easy to apply clinical
technique to shape the infants’ microbiome. Its consistent
provision shapes the oral microbiome of the preterm infant
and helps to accelerate its maturation [134].
10. Concluding Remarks
The available data convincingly support the hypothesis that
the pre- and postnatal microbiome contributes to premature
delivery and to the acute sequelae in the preterm infant.
Despite the tremendous scientific progress, we have just
scratched the surface to understand the consequences of
aberrant microbiota and their dynamic changes to disease
initiation and progression. The current data convincingly
highlight their impact on nosocomial infection and NEC,
which constitute not only a tremendous disease burden to
the preterm infant but more importantly entail life-long
consequences and considerable lethality. Nonetheless, for
most of the acute complications and short-term sequelae
including pulmonary and cerebral problems a clear cause-
relationship is still missing. It remains to be determined
whether pathogenic microbiota also account for the dis-
tortion of long-term somatic and psychomotor develop-
ment in preterm infants which did not suffer from severe
acute complications like infection or cerebral hemorrhage.
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Therefore, comprehensive and long-term oriented research
efforts are urgently needed to cover these important and clin-
ically highly relevant aspects. A comprehensive and mech-
anistic understanding of the connection between microbial
dysbiosis and disease initiation and progression will help
to develop new therapeutic concepts aiming to control and
restore physiologic microbial structures. Further important
topics of research are to gain detailed knowledge onmicrobial
structures and how to avoid of sample contamination and to
enable the comparability of studies with respect to techniques
and sample preparation [135]. It remains an open question
how our lifestyle habits and the genetic background impact
the microbiome of the pregnant woman and the frequency of
preterm born infants.
The successful implementation of postnatal probiotic
therapy and further clinical guidelines raises hopes to reduce
the maternal and fetal disease burden in the near future
and to come to a targeted or even personalized medicine.
Next steps can be derived from the observational studies
and should include (1) the design of point-of-care techniques
to determine microbial structures onsite and in real time
to immediately identify the mother and infant at risk, (2)
evaluation of the benefits of personalized medicine strate-
gies of vaginal fluid or feces transplantation to the fetus
and newborn, (3) the development of new strategies to
detect bacterial infection with high prediction accuracy to
avoid unnecessary and prolonged antibiotic therapy and
subsequent microbial dysbiosis, and (4) to test more potent
alternatives to current classical probiotics including mixtures
of different bacterial strains and bacterialmetabolites. Each of
these areas poses tremendous challenges and opportunities to
finally reduce the rates of prematurity and of the associated
morbidities. Opening and reaching these new frontiers in
perinatal science offer the opportunity to come closer to
efficient prevention of preterm birth, which poses an ever
greater global burden and challenge.
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